LifeMD, Inc.

LFMD Healthcare Health Information Services

LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024.

Revenue
−3.55%
EPS
−166.7%
Free cash flow
−247.5%

Quarter to June 2026, against a year earlier

2.36 0.07 +3.06%
Market cap
$110.4M
P/E
0.0×
Fwd P/E
−4.4×
Dividend yield
—
F-score
6/9
Altman Z
−0.02
Beneish M
−3.67
Dividend safety
n/a

LifeMD, Inc. (LFMD) EV/Sales

Alert me on EV/Sales

As of 6 November 2026, LifeMD, Inc. (LFMD) trades at a EV/Sales of 0.5×. Over the past ten years it has ranged from 0.3× (March 2023) to 11.5× (February 2021); the current reading is higher than 10% of that period. That is below the Health Information Services industry median of 2.3× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 0.7× (44.21%)
FY2024 1.2× (31.26%)
FY2023 1.8× 261.12%
FY2022 0.5× (29.56%)
FY2021 0.7× (69.31%)
FY2020 2.3× 419.32%
FY2019 0.4× (39.73%)
FY2018 0.7× (82.09%)
FY2017 4.1× 168.10%
FY2016 1.5× (46.59%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.0× 24.71%
Mar 2026 0.8× 14.99%
Dec 2025 0.7× (62.65%)
Sep 2025 1.8× (49.91%)
42 more quarters

Against its own ten years

Low 0.3× High 11.5×
Ten-year median 1.6×
Current reading's percentile 11

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on LFMD